Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Non-interventional, Longitudinal Study of the Treatment Journey of Adult Patients With Hyperkalemia

NCT05408039 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT05408039
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05408039 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Non-interventional, Longitudinal Study of the Treatment Journey of Adult Patients With Hyperkalemia
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
July 14, 2022
Completion date
December 19, 2024
Enrollment
1,331 (actual)
Sites
74

Conditions

As the registry lists them; a condition with its own page is linked.

hyperkalemia